Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Codagenix-Serum Join Fray To Develop SARS-CoV-2 Vaccine

Feb 14 2020

• By Vibha Ravi

Coronavirus_Microscopic — War Against SARS-CoV-2 Sees Several Alliances • Source: Shutterstock

Related Content

VGXI Gears To Support Production Of New Coronavirus Vaccine

Feb 03 2020

GSK Joins Race To Tackle Coronavirus

Feb 03 2020

Venture Funding Deals: Generation Bio Raises $110m For Non-Viral Gene Therapies

Feb 07 2020

Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany

Jan 29 2020

Epidemic Expert Kang On Tackling nCoV And Science As A Leveler

Jan 31 2020

Asia Deal Watch: China’s BravoVax, US-based GeoVax Team Up On Coronavirus Vaccine

Jan 31 2020

Coronavirus: Can Companies Achieve Vaccine Ambition?

Jan 28 2020

Moderna, Inovio Coronavirus Vaccine Candidates Fast-Tracked By International Coalition

Jan 27 2020

Related Companies

Codagenix Inc.

Serum Institute of India Pvt. Ltd.

Novartis AG

Merck & Co., Inc.

Johnson & Johnson

GeoVax Labs, Inc.

Inovio Pharmaceuticals, Inc.

Additional Topics

India Asia Pacific Research & Development Vaccines Biologics Coronavirus COVID-19 BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window